TSS
KRON

Two Sigma Securities’s Kronos Bio KRON Stock Holding History

Two Sigma Securities’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,532
Closed -$13.8K – 1864
2024
Q4 		$13.8K Buy
14,532
+3,410
+31% +$3.22K ﹤0.01% 1384
2024
Q3 		$11.1K Buy
+11,122
New +$12.3K ﹤0.01% 2576

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Two Sigma Securities's KRON Position: Q1 2025 in Review

Two Sigma Securities sold out of Kronos Bio (KRON) in Q1 2025, closing a stake of 14,532 shares — an estimated $13.8K sold.

Two Sigma Securities first reported a position in KRON in Q3 2024 and held it in 2 quarters. The position peaked at $13.8K in Q4 2024. 47 funds tracked by Wall St. Rank hold KRON as of Q1 2025.

  • Two Sigma Securities reported no remaining Kronos Bio position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 14,532 Kronos Bio shares in Q1 2025, an estimated $13.8K.
  • Two Sigma Securities first reported a position in Kronos Bio in Q3 2024 and held it in 2 quarters.
  • Two Sigma Securities's Kronos Bio position peaked at $13.8K in Q4 2024.
  • 47 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.